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Целта на оваа студија беше да се евалуираат можните причини  за појава на ендометријална хи-
перплазија во перименопауза. Материјал и методи: Беа анализирани 71  пациентка  со неправил-
но  крвавење, на возраст од 40-50 години, кај кои беше индицирана фракционирана киретажа. 
Зависно од хистопатолошкиот наод ги поделивме  во 2 групи: група 1- со наод за ендометријална 
хиперплазија, група 2- атрофичен или ендометриум со дефициентни секреторни промени. Од-
редивме  индекс на телесна маса (БМИ), обезитет дефиниран со БМИ > 30 kg/m2, измеривме 
крвен притисок (cut-off вредност 135/90 mmHg), обем на струк (cut-off вредност 88 см), како и 
податоци од анамнезата (возраст, физичка активност, тип на исхрана, пушење цигари).  Сите 
овие податоци беа анализирани  како етиолошки фактори во појавата на ендометријална хипер-
плазија. Резултати: Средна возраст на пациентките беше околу 47 години, а добиените резултати 
беа многу слични во двете испитувани групи. БМИ и обем на струк беа зголемени, хипертензија 
имаа повеќе од 60% од пациентките, но не беше утврдена статистичка значајност.  Најголем дел 
беа со средно образование, а живеењето во град статистички значајно го зголемува ризикот за 
ендометријална хиперплазија (p< 0,05). Што се однесува до животниот стил (физичка активност, 
калорична исхрана, пушење), резултатите покажаа дека мал дел се активни, речиси половина 
од нив конзумираат калорична храна и пушат, но без статистичка сигнификантност. Заклучок: 
Зголемената телесна тежина и покачениот крвен притисок  имаат големо влијание врз започну-
вање и прогресија на патолошки промени на ендометриумот. Како клинички доктори секогаш 
треба да помислиме на хиперплазија  кај обезни и пациентки со хипертензија, кои неправилно 
крвават. Воедно треба и да ги едуцираме за промена на животниот стил, со цел спречување на 
гинеколошки и интернистички морбидитети.
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The aim of this study was to evaluate the possible reasons for the emergence of endometrial hyper-
plasia in perimenopause. Material and methods: A total of 71 patients with irregular bleeding were 
analyzed, at the age of 40-50 years, who should have undergone diagnostic curettage. Depending 
on the histopathological findings, we divided them into 2 groups: group 1-findings for endometrial 
hyperplasia, group 2 - atrophic or endometrium with deficient secretory changes. Body mass index 
(BMI) was determined (obesity defined with BMI >30 kg/m2); we measured blood pressure (cut-off 
value was 135/90 mmHg), waist circumference (cut-off value was 88 cm) as well as data of anamnesis 
(age, physical activity, type of diet, smoking cigarettes). All these data were analyzed as etiological 
factors in the emergence of endometrial hyperplasia.Results: The mean age of patients was 47 years, 
and the results obtained were very similar in both examined groups. BMI and waist circumference 
were increased, more than 60% of patients had hypertension, but not all had a statistical signifi-
cance. Most of them were with completed secondary education, and city living statistically signifi-
cantly increases the risk of endometrial hyperplasia (p <0.05). As for the lifestyle (physical activity, 
caloric diet, smoking), the results have shown that a small number of patients are active, almost 
half of them consume caloric food and smoke, but without a statistical significance.Conclusion: In-
creased body weight and elevated blood pressure have a major impact on the onset and progression 
of pathological changes in the endometrium. As clinicians, we should always think of hyperplasia in 
obesity and patients with hypertension who are irregularly bleeding. At the same time, we should 
educate them to change the lifestyle in order to prevent gynecological and internistic morbidity.
Abstract
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6Introduction
Endometrial hyperplasia is one of the 
common causes of irregular bleeding in 
the perimenopause period 1. The thick-
ening of the endometrium occurs due to 
excess estrogen, progesterone deficiency 
(anovulation), and secretory transforma-
tion of the endometrium is avoided. Cut-
off value of the perimenopausal endo-
metrium is 11 mm; higher values suggest 
hyperplasia2. Comparison of  histological 
features is classified into 4 groups (by 
WHO): simplex, complex, simplex atyp-
ical and complex atypical hyperplasia3. 
This condition most commonly occurs 
around 50 years of age in women, but it 
is also possible in the reproductive pe-
riod. By nature, it is benign, but a ma-
lignant transformation is possible too. 
In the etiology, several risk factors are 
mentioned: estrogen dominance, obe-
sity, PCO syndrome, hypertension, dia-
betes, smoking, genetic predisposition, 
etc.4  Symptoms that indicate the pres-
ence of endometrial hyperplasia are ir-
regular menstrual bleeding, bleeding in 
menopause. The diagnosis is made by 
ultrasound examination, hysteroscopy, 
endometrial biopsy, curettage5. Regard-
ing treatment, depending on the type of 
hyperplasia, it can be conservative, with 
hormone therapy (gestagenic, oral, intra-
uterine device with gestagen) in hyper-
plasia without atypia, surgical removal 
(hysterectomy) in atypical hyperplasia, 
and in unsuccessful treatment with ge-
stagens6. Obesity as a clinical entity is 
defined by overweight (BMI body mass in-
dex> 30), according to the World Health 
Organization7. The mechanism is carried 
out in several ways: it reduces the syn-
thesis of sex hormone binding globulin 
(SHBG), increased conversion of andro-
gens to estrogen in the peripheral fat tis-
sue, then anovulation with low proges-
terone synthesis, etc.8
Unconcentrated estrogen action is a key 
point in the appearance of endometri-
al irregularities, including endometrial 
hyperplasia. According to the NHANES 
(National Health and Nutrition Survey), 
the age group of 40-59 years old is classi-
fied as obese, as a percentage of 68.1% of 
all respondents9. During this period, vis-
ceral fatty tissue, which is metabolic, is 
most active, increases insulin resistance, 
the risk of inflammatory, cardiovascular 
diseases, diabetes. The most suitable in-
dicator of the amount of visceral fatty 
tissue is the waist circumference (up to 
88 cm) and also the ratio of the waist cir-
cumference and hips (> 0.85). These val-
ues, together with BMI are the tools used 
in the diagnosis of obesity10,11. The prev-
alence of hypertension (elevated blood 
pressure) in the total population is 30-
33% 12. The diagnosis is made after sev-
eral consecutive measurements of blood 
pressure, and the median is taken for 
consideration. If the values are 135 mm 
Hg for systolic and 90 mm Hg for diastol-
ic pressure, hypertension is diagnosed 13. 
According to Women‘s Health Study, in 
over 40,000 healthy women over 45 years 
of age, elevated blood pressure increases 
cardiovascular risk, as well as the risk of 
type 2 diabetes14. The increase in systol-
ic blood pressure is mainly due to an in-
crease in vascular resistance in arterial 
vessels combined with atherosclerotic 
changes in their wall. Hormonal chang-
es in menopausal transition are also sig-
nificantly affected15. Insulin resistance 
adversely affects blood pressure, body 
weight, lipid metabolism, and the onset 
of metabolic syndrome16,17. 
The aim of this study was to evaluate 
the possible reasons for the emergence 
of endometrial hyperplasia in perimeno-
pause.
Material and methods
This study included 71 patients between 
the age of 40 and 50 who came to the Uni-
versity Gynecology and Obstetrics Clinic 
in Skopje  because of irregular uterine 
bleeding. Medical history was obtained 
from all patients (type and amount of 
bleeding, age, physical activity, type of 
diet, BMI determination, blood pres-
sure). Then a clinical examination fol-
lowed (under a speculum, an ultrasound 
examination performed with Voluson 
730 pro machine, vaginal device) and an 
indication for fractional curettage was 
set. After proper anesthesia preparation, 
short-term intravenous anesthesia was 
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7performed by the curettage (the obtained 
material was placed separately in two 
vials - cervix and cavum uteri and sent 
to histological analysis). The histopatho-
logic analyses were performed at the In-
stitute of Oncology and Radiology- Sko-
pje. After obtaining the results, patients 
were divided into two groups, depend-
ing on the histological finding: group 1 
- with finding for endometrial hyperpla-
sia, group 2 - atrophic or endometrium 
with deficient secretory changes. Possi-
ble etiological factors in the occurrence 
of endometrial hyperplasia (BMI, volume 
of structure, hypertension, age, place of 
residence, physical activity, type of diet, 
smoking of cigarettes, estrogen levels, 
reproductive history) were analyzed.
Inclusion criteria - patients between the 
age of 40 and 50 with irregular bleeding. 
Exclusion criteria - patients with hema-
tological diseases, application of hor-
mone therapy (contraceptives, replace-
ment therapy, Tamoxifen).
Statistical analysis- The SPSS program, 
version 20 was used for analysis of the 
results in this study. Variables were an-
alyzed with standard deviation (SD) and 
percent, t-test, chi-square test. Values of 
p <0.05 were considered statistically sig-
nificant.
Results
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Table 1.  Univariant analysis of variables - basic linear model
Variables With hyperplasia(N=39)
Without 
hyperplasia 
(N=32)
Statistical 
significance
BMI(kg/m2) 32.0±5.2 32.7±6.6 NS
Waist circumference (cm) 88.2±9.1 90.7±12.3 NS
High blood pressure
• systolic (mmHg)
• diastolic(mmHg)
28 (71.8%)
• 138.9±16.6
• 88.2±9.7
20 (62.5%)
• 138.7±12.0
• 87.8±6.7
NS
NS
Age 46.9±1.6 47.7±1.5 NS
Living in 
• city
• village
• 17 (44%)
• 22 (56%)
• 17 (22%)
• 15 (78%)
P<0.05
P<0.05
Physically active 3 (7.7%) 3 (9.3%) NS
Caloric diet 16 (41.0%) 15 (46.8%) NS
Education
• primary
• secondary
• university
• 9 (23.1%)
• 23 (58.9%)
• 7 (17.9%
• 11 (34.3%)
• 17 (53.1%)
• 4 (12.5%)
NS 
NS 
NS
Smokers 20 (51.2%) 15 (46.8%) NS
Table 1 shows the analyzed variables. 
Body mass index (BMI) in the hyperpla-
sia group was median 32 ± 5.2, and in the 
group without hyperplasia 32.7 ± 6.6. The 
waist circumference was 88.2 ± 9.1 and 
90.7 ± 12.3 in both groups, respectively. 
Hypertension was found in 71.8% of wom-
en in the hyperplasia group and 62.5% of 
the women without hyperplasia with a 
mean blood pressure value of 138.9 ± 16.6 
/ 88.2 ± 9.7 mmHg vs. 138.7 ± 12.0 / 87.8 ± 
6.7 mmHg, respectively. 
The mean age in the examined group was 
46.9 ± 1.6 years versus 47.7 ± 1.5 years in 
the control group. Regarding the place of 
residence, 44% of women with hyperpla-
sia live in the city, and 56% in the village 
vs. 22% of women in the control group 
who are from the city, and 78% from 
the village. Living in a city statistically 
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significantly increases the risk of endo-
metrial hyperplasia (p <0.05). Physical-
ly active were only 7.7% of women with 
hyperplasia, and non-significantly more 
than 9.3% of women without hyperpla-
sia. Caloric diet was used by 41% of the 
investigated group versus 46.8% of the 
control group.
In terms of education, secondary edu-
cated women were dominant in both 
groups 58.9% vs. 53.1%, respectively. The 
percentage of smokers was high in both 
groups - 51.2% in the hyperplasia group 
versus 46.8% in the group of women 
without hyperplasia.
Source Type III Sum of Squares Df
Mean 
Square F Sig.
Model 22,928a 11 2.084 8.159 .000
HTA .049 1 .049 .192 .663
city 1.112 1 1.112 4.353 .041
activity .000 1 .000 .000 .983
diet .056 1 .056 .217 .643
education .198 2 .099 .388 .680
smoking .089 1 .089 .350 .556
BMI .005 1 .005 .018 .894
age .444 1 .444 1.737 .193
circumference .006 1 .006 .023 .880
Error 15.072 59 .255   
Total 38.000 70    
Table 2.  Univariate analysis of  hyperplasia
Table 2 shows the univariate analysis of hyperplasia as a dependent variable.
The results have shown that all variables have an independent impact on hyperpla-
sia, other than the place of living, i.e. living in the city. 
Discussion
Irregular uterine bleeding in the period 
of perimenopause is the most common 
symptom for which patients pay visit to 
a gynecologist. This is due to different 
diseases of the reproductive system, but 
also other diseases (internistic). Often 
these are benign conditions (polyps, hy-
perplasia, atrophic endometrium, defi-
cient secretory phase, etc.), but premalig-
nant and malignant conditions (atypical 
hyperplasia, carcinoma) can occur 18.
Patients need complex evaluation, to di-
agnose the condition, but also to detect 
additional risk factors that could lead to 
endometrial pathology (anovulatory cy-
cles, age, parity, obesity, hypertension, 
diabetes, metabolic syndrome, etc.). In 
the study of Ozdemir et al. (2014), nu-
merous non-gynecological factors were 
analyzed that affected the occurrence 
of endometrial pathology, including the 
occurrence of cancers. They proved the 
impact of obesity, hypertension, meta-
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bolic syndrome, lipid imbalance on the 
endometrium5. The focus in this study 
was the analysis of endometrial hyper-
plasia and the risk factors for its appear-
ance. Numerous studies in the world 
have also proven this association (along 
with increased BMI, increased waist cir-
cumference, waist/ hip ratio). Hormonal 
imbalance in the perimenopause period 
is crucial in the accumulation of adipose 
tissue, especially in the abdomen19. In 
our study the average age of patients was 
47 years. The results confirmed hyper-
tension as a risk factor, and this is most 
often associated with increased BMI, in-
creased waist circumference, physical 
inactivity, caloric diet, and smoking. The 
incidence was similar in both examined 
groups and was also present in several 
cases of endometrial cancer (along with 
obesity, but this pathology was not the 
subject of our research), without statis-
tical significance (Table 1). Life in the ur-
ban area significantly affects the occur-
rence of hyperplasia of the endometrium 
(Table 2). But, there is evidence in the 
world that all these factors are the cause 
of endometrial malignancies19.
Conclusion
Increased body weight and elevated blood 
pressure have a major impact on the 
onset and progression of pathological 
changes in the endometrium. In patients 
who are obese, with hypertension and ir-
regular bleeding, we should proceed with 
further evaluation, searching for meta-
bolic risk factors. Probably our area is re-
sponsible for the different phenotype of 
patients, as well as lifestyle and hence, we 
received different results in relation to 
similar studies conducted in America and 
Europe. In some future studies, the vari-
ables should be extended by analyzing ad-
ditional metabolic parameters (glycemia, 
insulinemia, hormone and lipid status) in 
order to confirm the impact of impaired 
metabolism on reproductive organs. In 
order to reduce the prevalence of this 
pathology in perimenopause, it is neces-
sary to educate patients to change their 
lifestyle, to lose weight, to increase phys-
ical activity, and to pay regular controls 
at gynecologist and internist offices. All 
these measures would help in preventing 
serious gynecological and cardiovascular 
diseases, which would result in reducing 
morbidity and mortality in perimeno-
pausal patients.
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